-
公开(公告)号:US20230138413A1
公开(公告)日:2023-05-04
申请号:US17904893
申请日:2021-02-24
申请人: FIRMENICH SA
摘要: The present disclosure relates to the field of delivery systems. Disclosed herein are a flavored composition, a process for preparing a flavored composition and consumer products including said flavored composition.
-
2.
公开(公告)号:US20230113816A1
公开(公告)日:2023-04-13
申请号:US18065409
申请日:2022-12-13
申请人: Givaudan SA
摘要: A seasoning composition suitable for application topically to a snack food, and in particular an uncooked snack food, the seasoning composition comprising a plurality of seasoning-containing granules.
-
公开(公告)号:US20230056545A1
公开(公告)日:2023-02-23
申请号:US17790718
申请日:2020-12-28
发明人: Noboru OTSUSHI
摘要: The present invention can provide a composition capable of improving an unpleasant taste caused by high-intensity sweeteners, in which the yeast odor is improved and/or the masking effect of the unpleasant taste caused by high-intensity sweeteners is sufficiently performed.
A composition for improving the unpleasant taste caused by high-intensity sweeteners, comprising an extract of yeast cell walls degraded by a cell wall lytic enzyme, in which the degraded extract contains 50 mass% or more of carbohydrates to the dry mass of the degraded extract.-
公开(公告)号:US11584769B2
公开(公告)日:2023-02-21
申请号:US15529349
申请日:2015-11-30
发明人: Indra Prakash , Cynthia Bunders
IPC分类号: C07H15/256 , A23L2/60 , A23L27/30 , A23L27/00 , A23L2/56
摘要: Novel diterpene glycosides and methods for purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycosides, as well as methods of using the diterpene glycosides are provided.
-
公开(公告)号:US20230052393A1
公开(公告)日:2023-02-16
申请号:US17455327
申请日:2021-11-17
发明人: Jingang SHI , Hansheng WANG , Xin SHI , Yi WANG , Wei Lyu , Yingxiang XIN , Thomas EIDENBERGER , Weiyao SHI
IPC分类号: A23L2/60 , A23L27/30 , A23L2/54 , A23L2/02 , A23F5/46 , A23L27/00 , A23L27/21 , A23L27/10 , A23L33/18 , A23L33/175 , A23L33/105 , A23L33/125 , A23L2/66 , A23L2/56 , A23C9/13 , A21D2/18 , A21D2/24 , A23L2/38 , A23L33/145 , A21D2/26 , A23C9/152 , A23C9/156
摘要: Sweetener and flavor compositions with improved taste profiles are disclosed. Also disclosed are methods of making and methods of using such sweetener and flavor compositions.
-
公开(公告)号:US20230031366A1
公开(公告)日:2023-02-02
申请号:US17961941
申请日:2022-10-07
申请人: PURECIRCLE SDN BHD
IPC分类号: A23L5/00 , A23L2/60 , A61K8/60 , A61Q19/00 , A23P10/40 , A23L29/00 , A23L29/10 , A23L29/20 , A23L29/206 , A23L29/219 , A23L29/30 , A23L27/00 , A23L27/30 , A23L5/40 , A23L33/21 , A61K47/26
摘要: A method for making highly soluble Stevia sweetener compositions is described. The resulting sweetener compositions readily provide high concentration solutions, and also possess superior taste qualities. The compositions can be used as sweeteners, sweetness enhancers, and flavor enhancers in foods, beverages, cosmetics and pharmaceuticals.
-
公开(公告)号:US20230028760A1
公开(公告)日:2023-01-26
申请号:US17778965
申请日:2020-12-03
发明人: Dattatreya BANAVARA , Srinivasan SUBRAMANIAN , Tanya DITSCHUN , Andrew PATRON , Angela DI PIETRO
摘要: The present disclosure generally relates to various formulations and uses of the compound: 3-((4-amino-2,2-dioxo-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2,2-dimethyl-N-propylpropanamide, which is also referred to herein a “TM1” and comestibly acceptable salts thereof. In some aspects, the disclosure provides compositions that include TM1, or a comestibly acceptable salt thereof. In some embodiments, the compositions are ingestible compositions, including, but not limited to, packaged food and beverage products and tabletop sweeteners. In some aspects, the disclosure provides certain compositions that include such flavanone derivatives, such as compositions that include such flavanone derivatives and one or more other sweeteners. In some other aspects, the disclosure provides methods of reducing the caloric content of a sweetened article, such as a sweetened food or beverage product.
-
公开(公告)号:US20230025283A1
公开(公告)日:2023-01-26
申请号:US17781608
申请日:2020-12-07
IPC分类号: A23L27/00 , A23L27/30 , A23J3/14 , A23J3/22 , A23L29/00 , A23L33/185 , C07D317/68
摘要: The present disclosure generally relates to various formulations and uses of the compound: N-(heptan-4-yl)benzo[d] [1,3]dioxole-5-carboxamide, which is also referred to herein a “TM1” and comestibly acceptable salts thereof. In some aspects, the disclosure provides compositions that include TM1, or a comestibly acceptable salt thereof. In some embodiments, the compositions are ingestible compositions, including, but not limited to, packaged food and beverage products. In some other aspects, the disclosure provides methods of reducing the caloric content of a flavored article, for example, by reducing the amount of caloric sweeteners, fatty products (such as cheese). In some other aspects, the disclosure provides methods of reducing the amount of monosodium glutamate (MSG).
-
公开(公告)号:US11547137B2
公开(公告)日:2023-01-10
申请号:US16693877
申请日:2019-11-25
申请人: Givaudan, S.A.
发明人: Frans Witteveen
摘要: A topical flavouring product of a solid flavouring dispersed in a non-aqueous continuous medium containing oleic acid and sodium oleate in the relative weight proportions of from 80:20-54:46. A method of applying to the surface of a comestible product a solid flavouring, comprising dispersion of the solid flavouring in a non-aqueous continuous medium in the presence of oleic acid and sodium oleate and its topical application to the product, the oleic acid and sodium oleate being present in the relative weight proportions of from 80:20-54:46.
-
公开(公告)号:US11547127B2
公开(公告)日:2023-01-10
申请号:US17657424
申请日:2022-03-31
发明人: Bradford C. Sippy
IPC分类号: A23L2/56 , A23L27/30 , A23L27/20 , A23L27/21 , A23L27/00 , A23L33/15 , A23L33/175 , A23L2/60
摘要: Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.
-
-
-
-
-
-
-
-
-